• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Digital health leaders on the most noteworthy events of 2023

Share:

January 2, 2024

Digital health executives reflected on pivotal healthcare events in 2023 for MobiHealthNews. Key highlights included the rise of generative AI like ChatGPT, Silicon Valley Bank’s unexpected downturn, and Medicaid disenrollment impacting vulnerable populations. They noted the DEA’s reconsideration of telemedicine restrictions, Apple’s Vision Pro launch blending VR and AR, and the industry’s push towards AI-driven healthcare. Concerns arose around AI’s rapid integration and Medicaid’s significant impact on community health.

Executives in the digital health space shared with MobiHealthNews the most notable events in healthcare in 2023, including generative AI moving into the mainstream, the rise of ChatGPT, the fall of Silicon Valley Bank and Medicaid disenrollment.

Matthew Stoudt, cofounder and CEO of AppliedVR

“Silicon Valley Bank was the clear Black Swan event of 2023 and sent a shockwave through the entire system. It was unprecedented and created a lot of uncertainty for founders and investors alike. That showed us all how fragile, yet also resilient, our innovation industry can be. What was really notable was that everyone came together – from the investors to other entrepreneurs – to figure out how to make it all work.”

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Ankit Gupta, CEO and founder of Bicycle Health

“As the COVID-19 Public Health Emergency ended, the DEA released proposed regulations that could restrict access to telemedicine, despite overwhelming support of its impact for patients. The proposed regulations ultimately received more than 38,000 comments from patients and leaders, convincing the DEA to rethink their proposed in-person requirement and work on an alternative. This was a critical moment for telemedicine at large, and stands as a major step in the right direction in protecting access to care.”

Amit Khanna, senior vice president and general manager of health at Salesforce

“Needless to say, the biggest surprise was generative AI – no one could’ve predicted how much it would dramatically change the tech landscape. After ChatGPT was released, tech companies had to pivot in a very short period to incorporate genAI capabilities into their tech stacks. This is a new chapter in tech that will fundamentally change how software is built and consumed. It is an ‘internet’ moment for tech – just like ‘internet’ changed all businesses fundamentally, genAI has the power to change the software industry.”

Munjal Shah, cofounder and CEO of Hippocratic AI

“The launch of ChatGPT from OpenAI was the most noteworthy event of 2023. For years, we have talked about the promise of AI, but it wasn’t intelligent enough. Now, we truly have AI that has 130 IQ vs. 60 IQ. Over the past several months, investors, hospital systems and digital health companies have moved quickly to invest capital and time into bringing the benefits of this technology to bear.”

Eran Orr, CEO of XRHealth

“The Apple Vision Pro was the biggest surprise this year. Prior to its launch, headsets were either completely VR or AR, but Apple took an entirely different approach by combining both for a mixed reality solution. The Apple Vision Pro is also not just about gaming but everyday usage that can eventually replace the computer. I was surprised that they came right out of the gate with a mixed reality solution.”

Ann Bilyew, SVP, health and group general manager, WebMD Ignite

“2023 has been a very tumultuous year – one of big swings up and down with equal doses of innovation and retrenchment. We had the launch of technologies with tremendous potential like AI/LLM, a reckoning following investor exuberance in digital health in 2021 and 2022, major regulatory moves from the OCR on digital marketing, and the cultural phenom of GLP-1 agonists.”

Russell Glass, CEO of Headspace

“We saw AI-driven health care become a topic of mainstream dialogue. While companies like ours have been using AI for several years, it’s been fascinating to watch the entire industry begin to put ideas into action and evaluate areas ripe for AI disruption. While I’m excited to see the continued adoption of innovative technologies like generative AI, I share others’ concerns about the risks. As an industry, we need to proceed very cautiously – especially those in the mental health space, given we serve what is arguably the nation’s most vulnerable population.”

Doug Hirsch, cofounder and chief mission officer at GoodRx

“It’ll be hard to forget Medicaid disenrollment, which impacted millions of Americans this year. Those who rely on Medicaid coverage no longer have access to vital healthcare because of procedural reasons like missing paperwork or outdated contact information. And this applies to some of our country’s most vulnerable populations. It’s not right, and we’re likely to see a very tangible impact on the health of communities in 2024 as a result.”

Source: Mobihealth News

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Integrated Passive Device Market is Expected to Witness Growth at a Rate of 9.65% for the Forecast Period of 2022-2029Integrated Passive Device Market is Expected to Witness Growth at a Rate of 9.65% for the Forecast Period of 2022-2029
  • ConcertAI Acquires CancerLinQ to Expand Real-World Data and AI Solutions for Cancer CareConcertAI Acquires CancerLinQ to Expand Real-World Data and AI Solutions for Cancer Care
  • Bayer’s older meds deliver a surprisingly good showBayer’s older meds deliver a surprisingly good show
  • Deepcell & NVIDA Partner to Develop Generative AI Models for Single Cell MorphologyDeepcell & NVIDA Partner to Develop Generative AI Models for Single Cell Morphology
  • Medicare Advantage Cost Challenges Insurers Adapt StrategiesMedicare Advantage Cost Challenges Insurers Adapt Strategies
  • How NLP can Uncover Social Determinants of Heart DiseaseHow NLP can Uncover Social Determinants of Heart Disease
  • What Does 2019 Hold for ASCs? 10 Trends to ConsiderWhat Does 2019 Hold for ASCs? 10 Trends to Consider
  • Medical Training Startup Touch Surgery Secures $70M in Debt FundingMedical Training Startup Touch Surgery Secures $70M in Debt Funding

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications